{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:17:03Z","timestamp":1784733423553,"version":"3.55.0"},"reference-count":109,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>The absence of robust and effective treatments for Alzheimer\u2019s disease remains a major challenge in modern medicine. As one of the leading causes of death, its increasing prevalence and complex chronic pathogenesis impose a substantial societal and healthcare burden, intensifying the need for effective therapeutic strategies. Current treatments remain limited, with minimal impact on cognitive decline in symptomatic patients. Curcumin, the bioactive ingredient in turmeric, has taken precedence over other natural products due to its potent antioxidative and anti-inflammatory properties. Numerous publications have extensively reported on the therapeutic effect of curcumin in animal models of Alzheimer\u2019s disease. However, no curcumin formulation has demonstrated consistent clinical efficacy against Alzheimer\u2019s or other neurodegenerative diseases to date. Over the years, many critics have argued that curcumin\u2019s undesirable chemical properties, mainly low bioavailability and rapid metabolism, pose significant barriers to its therapeutic use to target the brain. Considerable funding and research effort on emerging technologies such as nanoparticles and intranasal delivery continue to drive curcumin preclinical and clinical trials, prompting reflection on the rationale for continued investment. This narrative review critically dissects this disconnect, arguing that many purported benefits remain insufficiently substantiated, and identifying important opportunities where future research may hold promise for an effective treatment.<\/jats:p>","DOI":"10.3390\/antiox15050638","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:02:27Z","timestamp":1779375747000},"page":"638","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Translational Feasibility of Curcumin for Treatment of Alzheimer\u2019s Disease: A Critical Appraisal of Clinical Challenges"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1180-8631","authenticated-orcid":false,"given":"Jasmine Priya","family":"Virk","sequence":"first","affiliation":[{"name":"Macquarie Medical School, Macquarie University, Sydney, NSW 2109, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4021-2943","authenticated-orcid":false,"given":"Malika G.","family":"Fernando","sequence":"additional","affiliation":[{"name":"Macquarie Medical School, Macquarie University, Sydney, NSW 2109, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prita Riana","family":"Asih","sequence":"additional","affiliation":[{"name":"Macquarie Medical School, Macquarie University, Sydney, NSW 2109, Australia"},{"name":"Alzheimer\u2019s Research Australia, Sarich Neuroscience Research Institute, Nedlands, WA 6009, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4828-9363","authenticated-orcid":false,"given":"Ralph N.","family":"Martins","sequence":"additional","affiliation":[{"name":"Macquarie Medical School, Macquarie University, Sydney, NSW 2109, Australia"},{"name":"Alzheimer\u2019s Research Australia, Sarich Neuroscience Research Institute, Nedlands, WA 6009, Australia"},{"name":"School of Medicine, University of Western Australia, Nedlands, WA 6009, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"ref_1","unstructured":"(2022). GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: An analysis for the Global Burden of Disease Study 2019. Lancet Public Health, 7, e105\u2013e125."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"(2024). 2024 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement., 20, 3708\u20133821.","DOI":"10.1002\/alz.13809"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e12385","DOI":"10.1002\/trc2.12385","article-title":"Alzheimer\u2019s disease drug development pipeline: 2023","volume":"9","author":"Cummings","year":"2023","journal-title":"Alzheimer\u2019s Dement. Transl. Res. Clin. Interv."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1370\/afm.3050","article-title":"Clinically Important Benefits and Harms of Monoclonal Antibodies Targeting Amyloid for the Treatment of Alzheimer Disease: A Systematic Review and Meta-Analysis","volume":"22","author":"Ebell","year":"2024","journal-title":"Ann. Fam. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/jamaneurol.2025.0065","article-title":"Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease: Secondary Analysis of the TRAILBLAZER-ALZ and ALZ 2 Randomized Clinical Trials","volume":"82","author":"Zimmer","year":"2025","journal-title":"JAMA Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"20091","DOI":"10.3390\/molecules191220091","article-title":"The Chemistry of Curcumin: From Extraction to Therapeutic Agent","volume":"19","author":"Priyadarsini","year":"2014","journal-title":"Molecules"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9758\/cpn.2017.15.1.1","article-title":"Mechanisms of Alzheimer\u2019s Disease Pathogenesis and Prevention: The Brain, Neural Pathology, N-methyl-D-aspartate Receptors, Tau Protein and Other Risk Factors","volume":"15","author":"Kocahan","year":"2017","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1021\/acs.jmedchem.6b00975","article-title":"The Essential Medicinal Chemistry of Curcumin","volume":"60","author":"Nelson","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jphotochemrev.2009.05.001","article-title":"Photophysics, photochemistry and photobiology of curcumin: Studies from organic solutions, bio-mimetics and living cells","volume":"10","author":"Priyadarsini","year":"2009","journal-title":"J. Photochem. Photobiol. C-Photochem. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","article-title":"The amyloid cascade hypothesis for Alzheimer\u2019s disease: An appraisal for the development of therapeutics","volume":"10","author":"Karran","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/aps.2017.28","article-title":"Amyloid beta: Structure, biology and structure-based therapeutic development","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/s41467-019-09477-3","article-title":"Different soluble aggregates of A\u03b242 can give rise to cellular toxicity through different mechanisms","volume":"10","author":"De","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/j.1742-4658.2008.06836.x","article-title":"Amyloid-\u03b2 protofibril levels correlate with spatial learning in Arctic Alzheimer\u2019s disease transgenic mice","volume":"276","author":"Lord","year":"2009","journal-title":"FEBS J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","article-title":"A\u03b2 Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer\u2019s Disease","volume":"27","author":"Lacor","year":"2007","journal-title":"J. Neurosci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The Amyloid-\u03b2 Pathway in Alzheimer\u2019s Disease","volume":"26","author":"Hampel","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"10311","DOI":"10.1074\/jbc.M608207200","article-title":"Small Molecule Inhibitors of Aggregation Indicate That Amyloid \u03b2 Oligomerization and Fibrillization Pathways Are Independent and Distinct*","volume":"282","author":"Necula","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Caesar, I., Jonson, M., Nilsson, K.P.R., Thor, S., and Hammarstr\u00f6m, P. (2012). Curcumin Promotes A-beta Fibrillation and Reduces Neurotoxicity in Transgenic Drosophila. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0031424"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.2353\/ajpath.2009.090417","article-title":"Phenolic Compounds Prevent Alzheimer\u2019s Pathology through Different Effects on the Amyloid-\u03b2 Aggregation Pathway","volume":"175","author":"Hamaguchi","year":"2009","journal-title":"Am. J. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1074\/jbc.M404751200","article-title":"Curcumin Inhibits Formation of Amyloid \u03b2 Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid In Vivo*","volume":"280","author":"Yang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/cbdd.12552","article-title":"Curcumin Binding to Beta Amyloid: A Computational Study","volume":"86","author":"Rao","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"146160","DOI":"10.1016\/j.electacta.2025.146160","article-title":"Amyloid\u2013\u00df peptides interaction with curcumin: AFM and electrochemical characterisation","volume":"525","author":"Mascini","year":"2025","journal-title":"Electrochim. Acta"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3233\/JAD-170188","article-title":"The Mechanisms of Action of Curcumin in Alzheimer\u2019s Disease","volume":"58","author":"Tang","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1016\/j.apsb.2021.02.023","article-title":"Gains from no real PAINS: Where \u2018Fair Trial Strategy\u2019 stands in the development of multi-target ligands","volume":"11","author":"Sun","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.4103\/1673-5374.193234","article-title":"Neurofibrillary tangles in Alzheimer\u2019s disease: Elucidation of the molecular mechanism by immunohistochemistry and tau protein phospho-proteomics","volume":"11","author":"Metaxas","year":"2016","journal-title":"Neural Regen. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"a006247","DOI":"10.1101\/cshperspect.a006247","article-title":"Biochemistry and Cell Biology of Tau Protein in Neurofibrillary Degeneration","volume":"2","author":"Mandelkow","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.7150\/ijbs.57078","article-title":"Interaction between A\u03b2 and Tau in the Pathogenesis of Alzheimer\u2019s Disease","volume":"17","author":"Zhang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Lou, S., Gong, D., Yang, M., Qiu, Q., Luo, J., and Chen, T. (2024). Curcumin Improves Neurogenesis in Alzheimer\u2019s Disease Mice via the Upregulation of Wnt\/\u03b2-Catenin and BDNF. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25105123"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/14756360802364377","article-title":"Inhibition of glycogen synthase kinase by curcumin: Investigation by simulated molecular docking and subsequent in vitro\/in vivo evaluation","volume":"24","author":"Bustanji","year":"2009","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3233\/JAD-170351","article-title":"Curcumin Inhibits Tau Aggregation and Disintegrates Preformed Tau Filaments in vitro","volume":"60","author":"Rane","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1292\/jvms.11-0307","article-title":"Binding of Curcumin to Senile Plaques and Cerebral Amyloid Angiopathy in the Aged Brain of Various Animals and to Neurofibrillary Tangles in Alzheimer\u2019s Brain","volume":"74","author":"Mutsuga","year":"2012","journal-title":"J. Vet. Med. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1074\/jbc.M112.393751","article-title":"Curcumin Suppresses Soluble Tau Dimers and Corrects Molecular Chaperone, Synaptic, and Behavioral Deficits in Aged Human Tau Transgenic Mice*","volume":"288","author":"Ma","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3233\/JAD-170093","article-title":"Curcumin Ameliorates Neuroinflammation, Neurodegeneration, and Memory Deficits in p25 Transgenic Mouse Model that Bears Hallmarks of Alzheimer\u2019s Disease","volume":"60","author":"Sundaram","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Caruso Bavisotto, C., Marino Gammazza, A., Lo Cascio, F., Mocciaro, E., Vitale, A.M., Vergilio, G., Pace, A., Cappello, F., Campanella, C., and Palumbo Piccionello, A. (2020). Curcumin Affects HSP60 Folding Activity and Levels in Neuroblastoma Cells. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21020661"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Rodriguez Ospina, S., Blazier, D.M., Criado-Marrero, M., Gould, L.A., Gebru, N.T., Beaulieu-Abdelahad, D., Wang, X., Remily-Wood, E., Chaput, D., and Stevens, S. (2022). Small Heat Shock Protein 22 Improves Cognition and Learning in the Tauopathic Brain. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23020851"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/alzrt146","article-title":"Oral curcumin for Alzheimer\u2019s disease: Tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study","volume":"4","author":"Ringman","year":"2012","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1475-2891-11-79","article-title":"Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people","volume":"11","author":"DiSilvestro","year":"2012","journal-title":"Nutr. J."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Das, S.S., Gopal, P.M., Thomas, J.V., Mohan, M.C., Thomas, S.C., Maliakel, B.P., Krishnakumar, I.M., and Pulikkaparambil Sasidharan, B.C. (2023). Influence of CurQfen\u00ae-curcumin on cognitive impairment: A randomized, double-blinded, placebo-controlled, 3-arm, 3-sequence comparative study. Front. Dement., 2.","DOI":"10.3389\/frdem.2023.1222708"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/jcp.0b013e318160862c","article-title":"Six-Month Randomized, Placebo-Controlled, Double-Blind, Pilot Clinical Trial of Curcumin in Patients With Alzheimer Disease","volume":"28","author":"Baum","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/NEN.0b013e31803d3ae4","article-title":"Plasma A\u03b2 Levels Do Not Reflect Brain A\u03b2 Levels","volume":"66","author":"Freeman","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00401-011-0861-8","article-title":"Factors affecting A\u03b2 plasma levels and their utility as biomarkers in ADNI","volume":"122","author":"Toledo","year":"2011","journal-title":"Acta Neuropathol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2007.09.023","article-title":"The normal equilibrium between CSF and plasma amyloid beta levels is disrupted in Alzheimer\u2019s disease","volume":"427","author":"Giedraitis","year":"2007","journal-title":"Neurosci. Lett."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"105322","DOI":"10.1016\/j.ebiom.2024.105322","article-title":"Insights into the use of biomarkers in clinical trials in Alzheimer\u2019s disease","volume":"108","author":"Pascoal","year":"2024","journal-title":"eBioMedicine"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jagp.2017.10.010","article-title":"Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial","volume":"26","author":"Small","year":"2018","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Thota, R.N., Rosato, J.I., Dias, C.B., Burrows, T.L., Martins, R.N., and Garg, M.L. (2020). Dietary Supplementation with Curcumin Reduce Circulating Levels of Glycogen Synthase Kinase-3\u03b2 and Islet Amyloid Polypeptide in Adults with High Risk of Type 2 Diabetes and Alzheimer\u2019s Disease. Nutrients, 12.","DOI":"10.3390\/nu12041032"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"25741","DOI":"10.1038\/s41598-024-75204-8","article-title":"Critical assessment of anti-amyloid-\u03b2 monoclonal antibodies effects in Alzheimer\u2019s disease: A systematic review and meta-analysis highlighting target engagement and clinical meaningfulness","volume":"14","author":"Avgerinos","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13195-023-01321-7","article-title":"The therapeutic landscape of tauopathies: Challenges and prospects","volume":"15","author":"Cummings","year":"2023","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00251-017-0992-8","article-title":"The synergistic effects of \u03c9-3 fatty acids and nano-curcumin supplementation on tumor necrosis factor (TNF)-\u03b1 gene expression and serum level in migraine patients","volume":"69","author":"Abdolahi","year":"2017","journal-title":"Immunogenetics"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Cox, K.H.M., White, D.J., Pipingas, A., Poorun, K., and Scholey, A. (2020). Further Evidence of Benefits to Mood and Working Memory from Lipidated Curcumin in Healthy Older People: A 12-Week, Double-Blind, Placebo-Controlled, Partial Replication Study. Nutrients, 12.","DOI":"10.3390\/nu12061678"},{"key":"ref_51","first-page":"e12347","article-title":"No difference in retinal fluorescence after oral curcumin intake in amyloid-proven AD cases compared to controls","volume":"14","author":"Lochocki","year":"2022","journal-title":"Alzheimer\u2019s Dement. Diagn. Assess. Dis. Monit."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/jn\/nxab087","article-title":"Pharmacokinetics of a Single Dose of Turmeric Curcuminoids Depends on Formulation: Results of a Human Crossover Study","volume":"151","author":"Tenon","year":"2021","journal-title":"J. Nutr."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1093\/jn\/nxaa299","article-title":"Evaluation of Cognitive Performance following Fish-Oil and Curcumin Supplementation in Middle-Aged and Older Adults with Overweight or Obesity","volume":"150","author":"Kuszewski","year":"2020","journal-title":"J. Nutr."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s13596-023-00737-8","article-title":"Improving cognitive function with intermittent dose escalation of curcumin extract in chemotherapy-induced cognitive impairment patients: A randomized controlled trial","volume":"24","author":"Laksmidewi","year":"2024","journal-title":"Adv. Tradit. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.clnu.2014.12.019","article-title":"Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis","volume":"34","author":"Panahi","year":"2015","journal-title":"Clin. Nutr."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1017\/S0007114516001203","article-title":"Curcumin and cognition: A randomised, placebo-controlled, double-blind study of community-dwelling older adults","volume":"115","author":"Brown","year":"2016","journal-title":"Br. J. Nutr."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"187","DOI":"10.18632\/aging.101149","article-title":"Curcumin supplementation improves vascular endothelial function in healthy middle-aged and older adults by increasing nitric oxide bioavailability and reducing oxidative stress","volume":"9","author":"Strahler","year":"2017","journal-title":"Aging"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"8416763","DOI":"10.1155\/2017\/8416763","article-title":"Oxidative Stress: Harms and Benefits for Human Health","volume":"2017","author":"Pizzino","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1212\/01.WNL.0000156156.13641.BA","article-title":"Evidence of increased oxidative damage in subjects with mild cognitive impairment","volume":"64","author":"Keller","year":"2005","journal-title":"Neurology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0006-8993(94)91670-5","article-title":"Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer\u2019s disease","volume":"645","author":"Palmer","year":"1994","journal-title":"Brain Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cbi.2008.05.003","article-title":"Antioxidant and radical scavenging properties of curcumin","volume":"174","author":"Ak","year":"2008","journal-title":"Chem.-Biol. Interact."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1021\/ja003823x","article-title":"How curcumin works preferentially with water soluble antioxidants","volume":"123","author":"Jovanovic","year":"2001","journal-title":"J. Am. Chem. Soc."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/archneurol.2012.85","article-title":"Antioxidants for Alzheimer Disease: A Randomized Clinical Trial With Cerebrospinal Fluid Biomarker Measures","volume":"69","author":"Galasko","year":"2012","journal-title":"Arch. Neurol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1039\/C9FO01063G","article-title":"Food matrix and co-presence of turmeric compounds influence bioavailability of curcumin in healthy humans","volume":"10","author":"Loveday","year":"2019","journal-title":"Food Funct."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0003-9861(02)00302-8","article-title":"Metal-mediated DNA damage induced by curcumin in the presence of human cytochrome P450 isozymes","volume":"405","author":"Sakano","year":"2002","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0304-3835(97)00442-4","article-title":"Strand scission in DNA induced by curcumin in the presence of Cu(II)","volume":"124","author":"Ahsan","year":"1998","journal-title":"Cancer Lett."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/0960327109359020","article-title":"Curcumin protects DNA damage in a chronically arsenic-exposed population of West Bengal","volume":"29","author":"Biswas","year":"2010","journal-title":"Hum. Exp. Toxicol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","article-title":"Inflammation as a central mechanism in Alzheimer\u2019s disease","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimer\u2019s Dement. Transl. Res. Clin. Interv."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"7606","DOI":"10.1073\/pnas.86.19.7606","article-title":"Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells","volume":"86","author":"Goldgaber","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11010-019-03638-0","article-title":"Curcumin inhibits BACE1 expression through the interaction between ER\u03b2 and NF\u03baB signaling pathway in SH-SY5Y cells","volume":"463","author":"Huang","year":"2020","journal-title":"Mol. Cell. Biochem."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Elbini-Dhouib, I., Doghri, R., Ellefi, A., Degrach, I., Srairi-Abid, N., and Gati, A. (2021). Curcumin Attenuated Neurotoxicity in Sporadic Animal Model of Alzheimer\u2019s Disease. Molecules, 26.","DOI":"10.3390\/molecules26103011"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"8370","DOI":"10.1523\/JNEUROSCI.21-21-08370.2001","article-title":"The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse","volume":"21","author":"Lim","year":"2001","journal-title":"J. Neurosci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Rajesh, Y., and Kanneganti, T.-D. (2022). Innate Immune Cell Death in Neuroinflammation and Alzheimer\u2019s Disease. Cells, 11.","DOI":"10.3390\/cells11121885"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","article-title":"Variant of TREM2 Associated with the Risk of Alzheimer\u2019s Disease","volume":"368","author":"Jonsson","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0197-4580(88)80079-4","article-title":"Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer\u2019s disease","volume":"9","author":"Rogers","year":"1988","journal-title":"Neurobiol. Aging"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0304-3940(96)12592-1","article-title":"Glial fibrillary acidic protein (GFAP) immunohistochemistry in human cortex: A quantitative study using different antisera","volume":"209","author":"Halliday","year":"1996","journal-title":"Neurosci. Lett."},{"key":"ref_78","first-page":"469","article-title":"Curcumin inhibits dose-dependently and time-dependently neuroglial cell proliferation and growth","volume":"24","author":"Ambegaokar","year":"2003","journal-title":"Neuroendocrinol. Lett."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"117170","DOI":"10.1016\/j.taap.2024.117170","article-title":"Curcumin ameliorates astrocyte inflammation through AXL in cuprizone-induced mice","volume":"494","author":"Zhang","year":"2025","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"148519","DOI":"10.1016\/j.brainres.2023.148519","article-title":"Curcumin modulates astrocyte function under basal and inflammatory conditions","volume":"1818","author":"Seady","year":"2023","journal-title":"Brain Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1038\/s41467-020-18046-y","article-title":"Steps towards standardized quantification of adult neurogenesis","volume":"11","author":"Zhao","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"14497","DOI":"10.1074\/jbc.M708373200","article-title":"Curcumin Stimulates Proliferation of Embryonic Neural Progenitor Cells and Neurogenesis in the Adult Hippocampus","volume":"283","author":"Kim","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"113299","DOI":"10.1016\/j.intimp.2024.113299","article-title":"Curcumin activates the Wnt\/\u03b2-catenin signaling pathway to alleviate hippocampal neurogenesis abnormalities caused by intermittent hypoxia: A study based on network pharmacology and experimental verification","volume":"143","author":"He","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s12272-023-01440-7","article-title":"Low-dose curcumin enhances hippocampal neurogenesis and memory retention in young mice","volume":"46","author":"Lee","year":"2023","journal-title":"Arch. Pharmacal Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/s41598-024-82571-9","article-title":"Curcumin reverses cognitive deficits through promoting neurogenesis and synapse plasticity via the upregulation of PSD95 and BDNF in mice","volume":"15","author":"Li","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-015-1449-5","article-title":"Analyzing dendritic spine pathology in Alzheimer\u2019s disease: Problems and opportunities","volume":"130","author":"Dorostkar","year":"2015","journal-title":"Acta Neuropathol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1021\/acschemneuro.3c00062","article-title":"Current Best Practices for Analysis of Dendritic Spine Morphology and Number in Neurodevelopmental Disorder Research","volume":"14","author":"Li","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"102091","DOI":"10.1016\/j.jchemneu.2022.102091","article-title":"Curcumin induces cortico-hippocampal neuronal reshaping and memory improvements in aged mice","volume":"121","author":"Gnecco","year":"2022","journal-title":"J. Chem. Neuroanat."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/S0731-7085(96)02024-9","article-title":"Stability of curcumin in buffer solutions and characterization of its degradation products","volume":"15","author":"Wang","year":"1997","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Vaz, G., Clementino, A., Mitsou, E., Ferrari, E., Buttini, F., Sissa, C., Xenakis, A., Sonvico, F., and Dora, C.L. (2022). In Vitro Evaluation of Curcumin- and Quercetin-Loaded Nanoemulsions for Intranasal Administration: Effect of Surface Charge and Viscosity. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14010194"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e93621","DOI":"10.1172\/jci.insight.93621","article-title":"Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer\u2019s disease","volume":"2","author":"Koronyo","year":"2017","journal-title":"JCI Insight"},{"key":"ref_92","first-page":"105","article-title":"Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine","volume":"11","author":"Ireson","year":"2002","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Josifovska, S., Panov, S., Hadzi-Petrushev, N., Mitrokhin, V., Kamkin, A., Stojchevski, R., Avtanski, D., and Mladenov, M. (2023). Positive Tetrahydrocurcumin-Associated Brain-Related Metabolomic Implications. Molecules, 28.","DOI":"10.3390\/molecules28093734"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Maiti, P., Manna, J., Thammathong, J., Evans, B., Dubey, K.D., Banerjee, S., and Dunbar, G.L. (2021). Tetrahydrocurcumin Has Similar Anti-Amyloid Properties as Curcumin: In Vitro Comparative Structure-Activity Studies. Antioxidants, 10.","DOI":"10.3390\/antiox10101592"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"38846","DOI":"10.1038\/srep38846","article-title":"Investigating the Neuroprotective Effects of Turmeric Extract: Structural Interactions of \u03b2-Amyloid Peptide with Single Curcuminoids","volume":"6","author":"Randino","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Santoro, A., Ricci, A., Rodriquez, M., Buonocore, M., and D\u2019Ursi, A.M. (2025). A Structural Effect of the Antioxidant Curcuminoids on the A\u03b2(1\u201342) Amyloid Peptide. Antioxidants, 14.","DOI":"10.3390\/antiox14010053"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1016\/j.bmcl.2013.03.069","article-title":"Novel racemic tetrahydrocurcuminoid dihydropyrimidinone analogues as potent acetylcholinesterase inhibitors","volume":"23","author":"Arunkhamkaew","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00210-025-04392-5","article-title":"A market and risk assessment of 125 turmeric supplements available in Australia, Germany, India, UK, and USA","volume":"399","author":"Seifert","year":"2026","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jconrel.2014.05.003","article-title":"Chitosan in nasal delivery systems for therapeutic drugs","volume":"190","author":"Casettari","year":"2014","journal-title":"J. Control. Release"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"7376","DOI":"10.1021\/jf100135h","article-title":"Curcumin Nanoparticles Improve the Physicochemical Properties of Curcumin and Effectively Enhance Its Antioxidant and Antihepatoma Activities","volume":"58","author":"Yen","year":"2010","journal-title":"J. Agric. Food Chem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1208\/s12248-012-9339-4","article-title":"Challenges in Development of Nanoparticle-Based Therapeutics","volume":"14","author":"Desai","year":"2012","journal-title":"AAPS J."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1208\/s12248-012-9444-4","article-title":"Highly Stabilized Curcumin Nanoparticles Tested in an In Vitro Blood\u2013Brain Barrier Model and in Alzheimer\u2019s Disease Tg2576 Mice","volume":"15","author":"Cheng","year":"2013","journal-title":"AAPS J."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2400304","DOI":"10.1002\/smtd.202400304","article-title":"Intranasal Delivery of Curcumin Nanoparticles Improves Neuroinflammation and Neurological Deficits in Mice with Intracerebral Hemorrhage","volume":"8","author":"Duan","year":"2024","journal-title":"Small Methods"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijpharm.2017.05.015","article-title":"Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates","volume":"526","author":"Barbara","year":"2017","journal-title":"Int. J. Pharm."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3233\/JAD-160289","article-title":"Aerosol Delivery of Curcumin Reduced Amyloid-\u03b2 Deposition and Improved Cognitive Performance in a Transgenic Model of Alzheimer\u2019s Disease","volume":"55","author":"McClure","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2405781","DOI":"10.1002\/smll.202405781","article-title":"Intranasal Delivery of Pure Nanodrug Loaded Liposomes for Alzheimer\u2019s Disease Treatment by Efficiently Regulating Microglial Polarization","volume":"20","author":"Feng","year":"2024","journal-title":"Small"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3233\/JAD-140798","article-title":"Inhalable Curcumin: Offering the Potential for Translation to Imaging and Treatment of Alzheimer\u2019s Disease","volume":"44","author":"McClure","year":"2015","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_108","unstructured":"DiMauro, T.M., DePuy Spine LLC, and DePuy Synthes Products Inc (2013). Curcumin Derivatives. (8383865B2), U.S. Patent."},{"key":"ref_109","unstructured":"Aggarwal, B., Knight, J., and Research Development Foundation (2005). Aerosol Delivery of Curcumin. (20050181036A1), U.S. Patent."}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/15\/5\/638\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:22:49Z","timestamp":1779376969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/15\/5\/638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":109,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["antiox15050638"],"URL":"https:\/\/doi.org\/10.3390\/antiox15050638","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]}}}